Skip to content
ppharmaranks
Menu

Ezogabine: uses, dosing, side effects & brands

Ezogabine is a medicine sold in the U.S. under one brand. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.

By the pharmaranks editorial teamReviewed against the FDA (openFDA label, NDC Directory & Enforcement) sourcesUpdated Jul 24, 2026How we research

Key facts

Available as
Tablet
Sold as
Potiga
Prescription?
Prescription only
Generic available?
Not in our catalog

Every ezogabine product we track (1)

Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.

Only one: Potiga.

Ezogabine and breastfeeding

From LactMed, the US National Library of Medicine’s Drugs and Lactation Database — quoted, not rewritten.

Ezogabine is no longer marketed in the US. Because no information is available on use of ezogabine during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. If ezogabine is required by the mother, it is not necessarily a reason to discontinue breastfeeding, but monitor the infant for drowsiness, agitation, adequate weight gain, and developmental milestones, especially in younger, exclusively breastfed infants and when using combinations of drugs.

Full LactMed record for ezogabine: levels in milk, effects in breastfed infants, and the drugs it would consider instead

National Institute of Child Health and Human Development, record revised January 15, 2025. LactMed states its information is not a substitute for professional judgement.

What people report to the FDA about ezogabine

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 45 reports naming ezogabine, and the FDA flagged 89% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • status epilepticus10 reports
  • seizure5 reports
  • confusional state4 reports
  • somnolence4 reports
  • treatment failure4 reports
  • multiple-drug resistance3 reports
  • sedation3 reports
  • abdominal pain2 reports

Read these as a signal, not a rate. A report does not mean ezogabine caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label section above.

Source: openFDA drug/event (FAERS), retrieved July 25, 2026.

Related calculators

Frequently asked questions

Can you take ezogabine with other medicines?

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run ezogabine against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

What forms does ezogabine come in?

Across the brands we track, ezogabine is currently marketed as tablet, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Is there a generic ezogabine?

We do not currently list a generic-labelled ezogabine product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.

Cite this page
APA
pharmaranks. (2026, July 24). Ezogabine: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/ezogabine
MLA
“Ezogabine: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/ezogabine.

We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.

Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.

Read the full FDA label for ezogabine on DailyMed (NIH) ↗.